NEA Management 13F-HR Quarterly holdings report by institutional manager

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL

OMB Number:		3235-0006
Expires:	Oct 31, 2018
Estimated average burden
hours per response:		23.8

COLUMN 1	COLUMN 2	COLUMN 3	COLUMN 4	COLUMN 5			COLUMN 6	COLUMN 7	COLUMN 8
			VALUE	SHRS OR	SH/	PUT/	INVESTMENT	OTHER	VOTING AUTHORITY
NAME OF ISSUER	TITLE OF CLASS	CUSIP	(x$1000)	PRN AMT	PRN	CALL	DISCRETION	MANAGER	SOLE	SHARED	NONE
AEROHIVE NETWORKS INC	COM	007786106	27,995	4,681,455	SH		DFND		4,681,455	0	0
AGILE THERAPEUTICS INC	COM	00847L100	900	133,488	SH		DFND		133,488	0	0
AKARI THERAPEUTICS PLC	ADR	00972G108	645	26,894	SH		DFND		26,894	0	0
ARCA BIOPHARMA INC	COM PAR $.001	00211Y407	7,243	1,460,209	SH		DFND		1,460,209	0	0
ARDELYX INC	COM	039697107	177,882	10,294,096	SH		DFND		10,294,096	0	0
ARQULE INC	COM	04269E107	4,713	2,520,316	SH		DFND		2,520,316	0	0
AURINIA PHARMACEUTICALS INC	COM	05156V102	7,233	2,546,843	SH		DFND		2,546,843	0	0
CARE COM INC	COM	141633107	16,761	3,260,989	SH		DFND		3,260,989	0	0
CATALYST BIOSCIENCES INC	COM	14888D109	3,040	652,380	SH		DFND		652,380	0	0
CHAMPIONS ONCOLOGY INC	COM	15870P307	8,359	1,562,500	SH		DFND		1,562,500	0	0
CHANNELADVISOR CORP	COM	159179100	5,534	556,692	SH		DFND		556,692	0	0
CLOVIS ONCOLOGY INC	COM	189464100	104,824	1,139,890	SH		DFND		1,139,890	0	0
CVENT INC	COM	23247G109	8,217	244,106	SH		DFND		244,106	0	0
DERMIRA INC	COM	24983L104	81,845	3,506,649	SH		DFND		3,506,649	0	0
EPIZYME INC	COM	29428V104	66,226	5,149,740	SH		DFND		5,149,740	0	0
EXELIXIS INC	COM	30161Q104	12,381	2,207,000	SH		DFND		2,207,000	0	0
GLYCOMIMETICS INC	COM	38000Q102	48,021	8,575,135	SH		DFND		8,575,135	0	0
GROUPON INC	COM CL A	399473107	144,004	44,172,953	SH		DFND		44,172,953	0	0
LEXICON PHARMACEUTICALS INC	COM	528872104	25,586	2,382,286	SH		DFND		2,382,286	0	0
LOXO ONCOLOGY INC	COM	548862101	31,328	1,792,207	SH		DFND		1,792,207	0	0
MILLENNIAL MEDIA INC	COM	60040N105	14,393	8,224,752	SH		DFND		8,224,752	0	0
NEVRO CORP	COM	64157F103	46,085	993,428	SH		DFND		993,428	0	0
OPOWER INC	COM	68375Y109	80,166	8,997,290	SH		DFND		8,997,290	0	0
OREXIGEN THERAPEUTICS INC	COM	686164104	7,826	3,709,000	SH		DFND		3,709,000	0	0
PARATEK PHARMACEUTICALS INC	COM	699374302	2,375	125,004	SH		DFND		125,004	0	0
RIGEL PHARMACEUTICALS INC	COM	766559603	8,011	3,243,150	SH		DFND		3,243,150	0	0
ROKA BIOSCIENCE INC	COM	775431109	6,280	3,220,433	SH		DFND		3,220,433	0	0
SUNESIS PHARMACEUTICALS INC	COM	867328601	4,609	5,689,644	SH		DFND		5,689,644	0	0
SUPERNUS PHARMACEUTICALS INC	COM	868459108	107,207	7,641,250	SH		DFND		7,641,250	0	0
TESARO INC	COM	881569107	355,056	8,854,255	SH		DFND		8,854,255	0	0
TRACON PHARMACEUTICALS INC	COM	89237H100	18,462	1,889,652	SH		DFND		1,889,652	0	0
TREVENA INC	COM	89532E109	49,801	4,811,691	SH		DFND		4,811,691	0	0
TRIVASCULAR TECHNOLOGIES INC	COM	89685A102	19,726	3,945,191	SH		DFND		3,945,191	0	0
ZHONE TECHNOLOGIES INC	COM	98950P884	6,550	4,781,290	SH		DFND		4,781,290	0	0
ZOSANO PHARMA CORP	COM	98979H103	8,548	2,158,543	SH		DFND		2,158,543	0	0